China Biotech Services Holdings Balance Sheet Health
Financial Health criteria checks 2/6
China Biotech Services Holdings has a total shareholder equity of HK$381.3M and total debt of HK$155.1M, which brings its debt-to-equity ratio to 40.7%. Its total assets and total liabilities are HK$630.6M and HK$249.2M respectively.
Key information
40.7%
Debt to equity ratio
HK$155.09m
Debt
| Interest coverage ratio | n/a |
| Cash | HK$33.24m |
| Equity | HK$381.32m |
| Total liabilities | HK$249.23m |
| Total assets | HK$630.55m |
Recent financial health updates
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13Recent updates
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk
Aug 12Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08Financial Position Analysis
Short Term Liabilities: 8037's short term assets (HK$157.1M) do not cover its short term liabilities (HK$211.5M).
Long Term Liabilities: 8037's short term assets (HK$157.1M) exceed its long term liabilities (HK$37.7M).
Debt to Equity History and Analysis
Debt Level: 8037's net debt to equity ratio (32%) is considered satisfactory.
Reducing Debt: 8037's debt to equity ratio has increased from 2.8% to 40.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 8037 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 8037 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.